Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

Acta Pharm Sin B. 2023 Aug;13(8):3321-3338. doi: 10.1016/j.apsb.2023.01.006. Epub 2023 Jan 10.

Abstract

Designing and manufacturing safe and effective vaccines is a crucial challenge for human health worldwide. Research on adjuvant-based subunit vaccines is increasingly being explored to meet clinical needs. Nevertheless, the adaptive immune responses of subunit vaccines are still unfavorable, which may partially be attributed to the immune cascade obstacles and unsatisfactory vaccine design. An extended understanding of the crosstalk between vaccine delivery strategies and immunological mechanisms could provide scientific insight to optimize antigen delivery and improve vaccination efficacy. In this review, we summarized the advanced subunit vaccine delivery technologies from the perspective of vaccine cascade obstacles after administration. The engineered subunit vaccines with lymph node and specific cell targeting ability, antigen cross-presentation, T cell activation properties, and tailorable antigen release patterns may achieve effective immune protection with high precision, efficiency, and stability. We hope this review can provide rational design principles and inspire the exploitation of future subunit vaccines.

Keywords: Antigen cross-presentation; Antigen release kinetics; B cell modulation; Dendritic cell subset targeting; Lymph node targeting; Subunit vaccine; T cell activation; Vaccine design.

Publication types

  • Review